The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan

被引：14
|
作者：
Wang, Cheng-Yi [1 ,2 ]
Lai, Chih-Cheng [3 ]
Wang, Ya-Hui [2 ,4 ]
Wang, Hao-Chien [5 ,6 ]
机构：
[1] Fu Jen Catholic Univ, Dept Internal Med, Cardinal Tien Hosp, New Taipei, Taiwan
[2] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan
[3] Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med, Tainan, Taiwan
[4] Fu Jen Catholic Univ, Med Res Ctr, Cardinal Tien Hosp, New Taipei, Taiwan
[5] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
来源：
NPJ PRIMARY CARE RESPIRATORY MEDICINE | 2021年 / 31卷 / 01期
关键词：
INHALED CORTICOSTEROIDS; PREVENTION;
D O I：
10.1038/s41533-021-00231-1
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
This study aims to investigate the prevalence of short-acting beta 2-agonist (SABA) overuse in asthma and the associated risk of acute exacerbation and mortality in Taiwan. We used the Taiwanese pay-for-performance asthma program database, which included patients aged between 12 and 100 years who were enrolled in the program between 2001 and 2015. Among a total of 218,039 patients, 34,641 (15.9%) patients are classified as SABA over-users. Compared with patients who did not receive inhaled corticosteroids (ICS) and collected <= 2 canisters, SABA over-users had a higher risk of severe exacerbations. SABA over-users had a higher risk of all-cause mortality compared with patients who did not receive ICS and collected <= 2 canisters. The overall prevalence of SABA overuse in Taiwan is 15.9%, and this is even higher in concomitant ICS users. In addition, the overuse of SABA is associated with an increased risk of severe exacerbation and death.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Short-acting β2-agonists (SABA) bronchodilator sales and outdoor mould in central France
    Caillaud, D. M.
    Martin, S.
    Segala, C.
    Dupuy, N.
    Thibaudon, M.
    Muti, D.
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2019, 9 (01)
  • [42] Asthma beliefs and overuse of short-acting beta-adrenergic receptor agonists among older adults
    Ishisaka, Yoshiko
    Ankam, Jyoti
    Feldman, Jonathan
    Busse, Paula
    Wisnivesky, Juan P.
    Federman, Alex D.
    [J]. JOURNAL OF ASTHMA, 2024,
  • [43] Effect of short-acting inhaler β2-agonists on serum cardiac troponin in wheezy infant
    Tasar, MA
    Bostanci, I
    Atli, Ö
    Dallar, Y
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2005, 26 (06) : 477 - 482
  • [44] Landscape of short-acting beta-agonists (SABA) overuse in Europe
    de Las Vecillas, Leticia
    Quirce, Santiago
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 132 - 144
  • [45] A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort
    Carlos Pedrozo-Pupo, John
    Pacheco Gallego, Manuel Conrado
    Banos Alvarez, Ivan de Jesus
    Jaller Raad, Rodolfo Antonio
    Caballero Pinilla, Andrea Carolina
    Reynales Londono, Humberto
    Bernal Villada, Laura
    Beekman, Maarten
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 1167 - 1178
  • [46] SHORT-ACTING AND LONG-ACTING β2-AGONISTS UPREGULATE ASTHMA-RELEVANT PRO-INFLAMMATORY MEDIATORS IN HUMAN AIRWAY EPITHELIAL CELLS WHILE SHORT-ACTING MUSCARINIC ANTAGONISTS DO NOT
    Kumar, K.
    Losa, F.
    Kebadze, T.
    Singanayagam, A.
    Edwards, M. R.
    Johnston, S. L.
    [J]. THORAX, 2019, 74 : A88 - A88
  • [47] Inhaled anticholinergics and short-acting beta2-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital
    Vezina, Kevin
    Chauhan, Bhupendrasinh F.
    Ducharme, Francine M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [48] Excess mortality in patients with asthma on long-acting β2-agonists
    Hasford, J.
    Virchow, J. C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) : 900 - 902
  • [49] High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortality
    Janson, Christer
    Wiklund, Fredrik
    Telg, Gunilla
    Stratelis, Georgios
    Sandelowsky, Hanna
    [J]. ERJ OPEN RESEARCH, 2023, 9 (03)
  • [50] Use of short-acting β2-agonists during pregnancy and the risk of pregnancy-induced hypertension
    Martel, Marie-Josee
    Rey, Evelyne
    Beauchesne, Marie-France
    Perreault, Sylvie
    Forget, Amelie
    Maghni, Karim
    Lefebvre, Genevieve
    Blais, Lucie
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (03) : 576 - 582
12345